AstraZeneca Gets in on ADC Therapeutics' Mega $200M Funding Round Post author:Sam Post published:October 22, 2017 Post category:BioPharma ADC Therapeutics announced it had raised $200M through an oversubscribed private placement. Source: BioSpace You Might Also Like Bay Area's Calithera Biosciences Rockets After Getting $53 Million Upfront in Cancer Deal With Incyte January 29, 2017 Checkmate Notches $27 Million and Taps Ex-FORUM Pharma Exec as COO June 15, 2017 Biogen Strikes $120 Million+ Deal For Remedy Pharma's Stroke Candidate May 14, 2017
Bay Area's Calithera Biosciences Rockets After Getting $53 Million Upfront in Cancer Deal With Incyte January 29, 2017